TCL Healthcare enters the High Dose Rate Brachytherapy solutions market in China

Eckert & Ziegler BEBIG GmbH and TCL Healthcare Equipment (Shanghai) Co., Ltd signed a joint venture agreement to enter the High Dose Rate Brachytherapy solutions market in China.

The parties will develop, manufacture and distribute an HDR afterloader for the Chinese market. The joint venture will trade under the name TCL Eckert & Ziegler BEBIG Healthcare (Wuxi) Co. Ltd. and is owned 51% by TCL Healthcare Equipment (Shanghai) Co., Ltd. and 49% by Eckert & Ziegler BEBIG GmbH.

TCL Healthcare Equipment (Shanghai) Co., Ltd. is part of the TCL Healthcare Group (a listed Chinese company) and Eckert & Ziegler BEBIG GmbH is part of Eckert & Ziegler AG. 


About TCL Healthcare Equipment (Shanghai) Co., Ltd. (TCL Healthcare Equipment)

TCL Healthcare Group, established in 2009, is one of the leading suppliers of healthcare diagnostic imaging products in China and a provider of  third-party imaging services.


About Eckert & Ziegler BEBIG GmbH (Eckert & Ziegler BEBIG)

Eckert & Ziegler BEBIG is a European-based group active in the medical device segment of the health care industry. Its core business is the production and distribution of medical products for the treatment of cancer using brachytherapy. The company headquarters are in Germany, with production facilities in Germany and in the USA, as well as offices throughout Europe, Asia and the USA. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents to support the international marketing and distribution of its product line. The company’s products and equipment are intended for use by oncologists, radiotherapists, urologists, ophthalmologists and medical physicists.

Posted in Homepage News, Portfolio News.